Community Research and Development Information Service - CORDIS

H2020

EBOVAC2

Project ID: 115861
Funded under

Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II

From 2014-12-01 to 2017-11-30, ongoing project

Project details

Total cost:

EUR 36 671 060

EU contribution:

EUR 22 790 820

Coordinated in:

France

Call for proposal:

H2020-JTI-IMI2-2014-02-single-stageSee other projects for this call

Funding scheme:

IMI2-RIA - Research and Innovation action

Objective

Coordinator

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France

EU contribution: EUR 14 467 474


RUE TOLBIAC
75654 PARIS
France
Activity type: Higher or Secondary Education Establishments

Participants

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE
United Kingdom

EU contribution: EUR 463 876


KEPPEL STREET
WC1E7HT LONDON
United Kingdom
Activity type: Higher or Secondary Education Establishments
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

EU contribution: EUR 1 971 720


University Offices, Wellington Square
OX1 2JD OXFORD
United Kingdom
Activity type: Higher or Secondary Education Establishments
CENTRE MURAZ
Burkina Faso

EU contribution: EUR 5 075 000


Avenue Mamadou Konate
NA BOBO-DIOULASSO
Burkina Faso
Activity type: Research Organisations
INSERM - TRANSFERT SA
France

EU contribution: EUR 371 500


Rue Watt 7
75013 PARIS
France
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Record Number: 209445 / Last updated on: 2017-03-27